PHI with peripheral arterial occlusive disease (PAOD)
How does this condition affect your private health insurance?
Periphere arterielle Verschlusskrankheit (pAVK), or Peripheral Artery Disease (PAD), is a common circulatory problem where narrowed arteries reduce blood flow to the limbs, most commonly the legs. It results from atherosclerosis, the buildup of plaque in the arteries. Symptoms range from mild or no symptoms to painful cramping in the hip, thigh, or calf muscles after activity (intermittent claudication). Severe pAVK can lead to critical limb ischemia, non-healing sores, infection, and gangrene, potentially necessitating amputation. It's a significant indicator of widespread atherosclerotic disease, increasing the risk of heart attack and stroke. Management involves lifestyle changes, medication, and sometimes revascularization procedures.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Symptoms typically appear gradually and intermittently, worsening with activity, over weeks to months. Initial presentation might be subtle claudication.
Duration of Illness (Lifetime)
Chronic and progressive. Requires lifelong management.
Cost of Treatment (Initial)
Initial diagnostic workup and conservative management (medication, lifestyle counseling) can range from a few hundred to a few thousand Euros. If revascularization (e.g., angioplasty) is needed, costs can be significantly higher, ranging from several thousand to tens of thousands of Euros.
Cost of Treatment (Lifetime)
Lifelong management includes regular consultations, medications, diagnostics, and potential repeated interventions (e.g., bypass surgery, stents). Costs can accumulate to tens of thousands to hundreds of thousands of Euros, especially if complications like critical limb ischemia or amputation occur.
Mortality Rate
pAVK itself is not a direct cause of immediate death, but it significantly increases the risk of cardiovascular mortality (heart attack, stroke) due to underlying systemic atherosclerosis. The 5-year mortality rate for patients with symptomatic pAVK is around 15-30%, higher for those with critical limb ischemia.
Risk of Secondary Damages
Very high. Potential secondary damages include critical limb ischemia, non-healing ulcers, infections, gangrene, limb amputation (5-10% of claudicants progress to critical limb ischemia, and 1-2% require amputation within 5 years), and significantly increased risk of myocardial infarction and stroke.
Probability of Full Recovery
Low. As a chronic, progressive atherosclerotic disease, complete 'recovery' where the arteries revert to their healthy state is not typical. Management focuses on slowing progression, alleviating symptoms, and preventing complications, but the underlying disease persists.
Underlying Disease Risk
Very high. pAVK is strongly associated with other atherosclerotic risk factors and diseases, including diabetes mellitus (20-30%), hypertension (50-70%), hyperlipidemia (30-50%), chronic kidney disease, and coronary artery disease (40-60%). Smoking is also a major risk factor.